SOPHiA GENETICS S.A.
NASDAQ:SOPHMedical - Healthcare Information Services
+$0.02 today
- Market cap
- $635.90M
- Beta
- 0.98
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$1.14
Volume 0.61M
Average 0.10M
SOPH Account Payables
Amounts the company owes suppliers for goods and services received.
SOPHiA GENETICS S.A.NASDAQ: SOPH
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables rises 175.0% from a year ago
Account payables stood at $12.67M at the end of Q1 FY2026, up 175.0% from a year earlier and up 41.4% from the prior quarter. Over 3 fiscal years it compounded at +34.8% a year.
Context
- Account payables amounted to 8.1% of total assets at the end of Q1 FY2026, up 4.9 pp from a year earlier.
- Account payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +175.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 5.32M USD
- Year-over-year change
- +175.1%
- 4-year CAGR
- +22.8%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.32M | +175.1% |
| FY2024 | 2024-12-31 | 1.93M | -14.4% |
| FY2023 | 2023-12-31 | 2.26M | +4.0% |
| FY2022 | 2022-12-31 | 2.17M | -7.1% |
| FY2021 | 2021-12-31 | 2.34M | — |
Account Payables vs competitors
How SOPH compares with its peers on the latest reported figures
- SOPH's Mar 2026 account payables of $12.67M is the 3rd highest of the 10 companies compared; the peer median is $6.02M.
- Its year-over-year change of +175.0% is the highest of 10, against a peer median of +18.4%.
- Account payables amounts to 8.1% of total assets for SOPH, versus a peer median of 1.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $70.51M | +18.4% | +21.3% | 2.9% | |
| Mar 2026 | $12.68M | +60.2% | +0.3% | 3.9% | |
| Mar 2026 | $12.67M | +175.0% | +34.8% | 8.1% | |
BLLNBillionToOne, Inc. | Jun 2026 | $12.21M | +53.6% | — | 1.7% |
| Mar 2026 | $11.69M | +30.7% | +28.4% | 2.8% | |
| Mar 2026 | $6.02M | -26.7% | -3.1% | 1.2% | |
| Mar 2026 | $5.09M | +60.1% | +2.2% | 1.0% | |
| Mar 2026 | $3.69M | -27.2% | -23.1% | 0.2% | |
| Mar 2026 | $3.07M | -9.3% | +1.8% | 1.8% | |
| Mar 2026 | $2.23M | +9.7% | +52.2% | 1.7% | |
| Peer median (excluding SOPH) | $6.02M | +18.4% | +2.0% | 1.7% | |
Competitors are the stored peer set for SOPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 192.96M | 161.31M | 123.25M | 80.23M | 70.29M |
| Short-term Investments | 72.36M | 17.31M | 0 | 0 | 0 |
| Net Receivables | 7.09M | 8.05M | 15.21M | 8.69M | 18.53M |
| Inventory | 5.73M | 5.16M | 6.48M | 5.87M | 6.35M |
| Other Current Assets | 775K | 731K | 345K | 835K | 758K |
| Total Current Assets | 282.86M | 196.26M | 148.05M | 99.41M | 99.08M |
| Property, Plant & Equipment (Net) | 15.96M | 21.4M | 23.1M | 19.38M | 18.05M |
| Goodwill | 8.3M | 8.19M | 9M | 8.34M | 9.56M |
| Intangible Assets | 7.38M | 11.78M | 18.19M | 20.66M | 26.34M |
| Long-term Investments | 0 | 0 | 0 | 0 | 1.98M |
| Tax Assets | 1.99M | 1.94M | 1.72M | 1.77M | 2.26M |
| Other Non-current Assets | 3.7M | 4.28M | 6.1M | 5.76M | 6.21M |
| Total Non-current Assets | 37.32M | 47.58M | 58.11M | 55.9M | 64.38M |
| Total Assets | 320.17M | 243.84M | 206.16M | 155.31M | 163.46M |
| Account Payables | 2.34M | 2.17M | 2.26M | 1.93M | 5.32M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 891K | 356K | 769K | 658K | 0 |
| Deferred Revenue | 4.07M | 3.43M | 9.49M | 5.73M | 16.72M |
| Other Current Liabilities | 9.16M | 10.27M | 13.58M | 11.23M | 1.68M |
| Total Current Liabilities | 28.6M | 26.81M | 35.62M | 26.8M | 50.53M |
| Long-term Debt | 0 | 0 | 0 | 13.24M | 47.73M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 424K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 4.92M | 2.85M | 3.42M | 4.18M | 5.04M |
| Total Non-current Liabilities | 16.17M | 16.9M | 19.09M | 32.02M | 65.78M |
| Total Liabilities | 44.77M | 43.71M | 54.71M | 58.82M | 116.31M |
| Common Stock | 3.33M | 3.46M | 4.05M | 4.19M | 4.81M |
| Retained Earnings | (211.35M) | (298.8M) | (377.78M) | (440.28M) | (519.28M) |
| Accumulated OCI | 12.54M | 23.96M | 53.98M | 61.04M | 89.15M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 275.4M | 200.13M | 151.44M | 96.49M | 47.15M |
| Total Debt | 13.06M | 16.74M | 18.6M | 30.03M | 63.02M |
| Net Debt | (179.9M) | (144.56M) | (104.65M) | (50.2M) | (7.27M) |
SOPHiA GENETICS S.A.
NASDAQ:SOPH
Intrinsic Alpha fair value
Locked
Current Price
$7.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.